These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9473022)

  • 21. HIV voluntary counseling and testing of couples during maternal labor and delivery: the TRIPAI Couples study.
    Melo M; Varella I; Castro A; Nielsen-Saines K; Lira R; Simon M; Yeganeh N; Rocha T; Bogo Chies JA; Santos B
    Sex Transm Dis; 2013 Sep; 40(9):704-9. PubMed ID: 23949585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of HIV-1 drug resistance in antiretroviral-naive pregnant Thai women.
    Auswinporn S; Jenwitheesuk E; Panburana P; Sirinavin S; Vibhagool A; Chantratita W
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):818-21. PubMed ID: 12757232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel CCR5 mutation selectively affects immunoreactivity and fusogenic property of the HIV co-receptor.
    Zhao XY; Lee SS; Wong KH; Chan KC; He ZM; Ma S; Ng F; Chan CC; Ho T; Ng MH; Zheng BJ
    AIDS; 2004 Aug; 18(12):1729-32. PubMed ID: 15280786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 32-bp deletion within the CCR5 locus protects against transmission of parenterally acquired human immunodeficiency virus but does not affect progression to AIDS-defining illness.
    Wilkinson DA; Operskalski EA; Busch MP; Mosley JW; Koup RA
    J Infect Dis; 1998 Oct; 178(4):1163-6. PubMed ID: 9806051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-receptor usage of HIV-1 primary isolates, viral burden, and CCR5 genotype in mother-to-child HIV-1 transmission.
    Ometto L; Zanchetta M; Mainardi M; De Salvo GL; Garcia-Rodriguez MC; Gray L; Newell ML; Chieco-Bianchi L; De Rossi A
    AIDS; 2000 Aug; 14(12):1721-9. PubMed ID: 10985308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCR-5 genotype and sexual transmission of HIV-1.
    O'Brien TR; Padian NS; Hodge T; Goedert JJ; O'Brien SJ; Carrington M
    AIDS; 1998 Mar; 12(4):444-5. PubMed ID: 9520179
    [No Abstract]   [Full Text] [Related]  

  • 27. Protective role of beta-chemokines associated with HIV-specific Th responses against perinatal HIV transmission.
    Wasik TJ; Bratosiewicz J; Wierzbicki A; Whiteman VE; Rutstein RR; Starr SE; Douglas SD; Kaufman D; Sison AV; Polansky M; Lischner HW; Kozbor D
    J Immunol; 1999 Apr; 162(7):4355-64. PubMed ID: 10201969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children.
    Ometto L; Bertorelle R; Mainardi M; Zanchetta M; Tognazzo S; Rampon O; Ruga E; Chieco-Bianchi L; De Rossi A
    J Infect Dis; 2001 Mar; 183(5):814-8. PubMed ID: 11181160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women.
    Philpott S; Weiser B; Tarwater P; Vermund SH; Kleeberger CA; Gange SJ; Anastos K; Cohen M; Greenblatt RM; Kovacs A; Minkoff H; Young MA; Miotti P; Dupuis M; Chen CH; Burger H
    J Infect Dis; 2003 Feb; 187(4):569-75. PubMed ID: 12599073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concordance between the CC chemokine receptor 5 genetic determinants that alter risks of transmission and disease progression in children exposed perinatally to human immunodeficiency virus.
    Mangano A; Gonzalez E; Dhanda R; Catano G; Bamshad M; Bock A; Duggirala R; Williams K; Mummidi S; Clark RA; Ahuja SS; Dolan MJ; Bologna R; Sen L; Ahuja SK
    J Infect Dis; 2001 Jun; 183(11):1574-85. PubMed ID: 11335892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of CCR5 expression in the placenta is associated with human immunodeficiency virus-1 vertical transmission.
    Behbahani H; Popek E; Garcia P; Andersson J; Spetz AL; Landay A; Flener Z; Patterson BK
    Am J Pathol; 2000 Dec; 157(6):1811-8. PubMed ID: 11106553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote.
    Gorry PR; Dunfee RL; Mefford ME; Kunstman K; Morgan T; Moore JP; Mascola JR; Agopian K; Holm GH; Mehle A; Taylor J; Farzan M; Wang H; Ellery P; Willey SJ; Clapham PR; Wolinsky SM; Crowe SM; Gabuzda D
    Virology; 2007 May; 362(1):163-78. PubMed ID: 17239419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV medical advances explored at retrovirus conference.
    Dorenbaum A; Miserez AR
    AIDS Policy Law; 2001 May; 16(10):4. PubMed ID: 11569980
    [No Abstract]   [Full Text] [Related]  

  • 34. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation.
    Kostrikis LG; Huang Y; Moore JP; Wolinsky SM; Zhang L; Guo Y; Deutsch L; Phair J; Neumann AU; Ho DD
    Nat Med; 1998 Mar; 4(3):350-3. PubMed ID: 9500612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV type 1 chemokine receptor usage in mother-to-child transmission.
    Salvatori F; Scarlatti G
    AIDS Res Hum Retroviruses; 2001 Jul; 17(10):925-35. PubMed ID: 11461678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCR5-delta 32 gene deletion in HIV-1 infected patients.
    Wang B; Palasanthiran P; Zeigler J; Cunningham A; Saksena NK
    Lancet; 1997 Sep; 350(9079):742. PubMed ID: 9291932
    [No Abstract]   [Full Text] [Related]  

  • 37. [Analysis of the 32 bp deletion in the CCR5 chemokine receptor gene in people from Moscow, infected with HIV-1].
    Shadrina MI; Kapylov VM; Miloserdova OV; Slominskiĭ PA; Limborskaia SA
    Genetika; 2000 May; 36(5):718-20. PubMed ID: 10867893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of the 32-bp CCR-5 deletion on HIV transmission and HIV disease progression in individuals with haemophilia.
    Pasi KJ; Sabin CA; Jenkins PV; Devereux HL; Ononye C; Lee CA
    Br J Haematol; 2000 Oct; 111(1):136-42. PubMed ID: 11091193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of CCR2 and CCR5 variants on HIV disease: abstract and commentary.
    Collman RG
    JAMA; 1997 Dec; 278(23):2113-4. PubMed ID: 9403430
    [No Abstract]   [Full Text] [Related]  

  • 40. Protective effect of CCR5 delta 32 heterozygosity is restricted by SDF-1 genotype in children with HIV-1 infection.
    Sei S; Boler AM; Nguyen GT; Stewart SK; Yang QE; Edgerly M; Wood LV; Brouwers P; Venzon DJ
    AIDS; 2001 Jul; 15(11):1343-52. PubMed ID: 11504955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.